Business Description
LeonaBio Inc
NAICS : 541714
SIC : 2833
ISIN : US04746L2034
Share Class Description:
LONA: Ordinary SharesTotal Employee Number:
19Description
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 97.94 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 30.7 | |||||
3-Year EPS without NRI Growth Rate | 30.2 | |||||
3-Year FCF Growth Rate | 18.2 | |||||
3-Year Book Growth Rate | -63.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 67.33 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.74 | |||||
9-Day RSI | 52.32 | |||||
14-Day RSI | 50.55 | |||||
3-1 Month Momentum % | -20.53 | |||||
6-1 Month Momentum % | 29.6 | |||||
12-1 Month Momentum % | 199.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.38 | |||||
Quick Ratio | 10.38 | |||||
Cash Ratio | 10.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.1 | |||||
Shareholder Yield % | 0.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -373.61 | |||||
ROA % | -237.17 | |||||
ROIC % | -353.66 | |||||
3-Year ROIIC % | -464.66 | |||||
ROC (Joel Greenblatt) % | -1842.75 | |||||
ROCE % | -103.14 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.66 | |||||
Price-to-Tangible-Book | 1.66 | |||||
EV-to-EBIT | -0.34 | |||||
EV-to-EBITDA | -0.35 | |||||
EV-to-FCF | -0.28 | |||||
| Price-to-Net-Current-Asset-Value | 1.74 | |||||
| Price-to-Net-Cash | 1.8 | |||||
Earnings Yield (Greenblatt) % | -294.12 | |||||
FCF Yield % | -63.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LONA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LeonaBio Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -24.11 | ||
| Beta | 0.8926 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.5 | ||
| Volatility % | 117.44 | ||
| 14-Day RSI | 50.55 | ||
| 14-Day ATR ($) | 0.737031 | ||
| 20-Day SMA ($) | 8.5245 | ||
| 12-1 Month Momentum % | 199.57 | ||
| 52-Week Range ($) | 2.95 - 14.21 | ||
| Shares Outstanding (Mil) | 9.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LeonaBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LeonaBio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 123 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 32 days | ||
| General meeting for 2026 | 2026-06-22 08:00 | 8.18 (-1.68%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 9.42 (-2.08%) | ||
| Annual report for 2025 | 2026-03-31 | 9.27 (+3.29%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 9.03 (-3.32%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 4.19 (-1.18%) | ||
| 0.1:1 Stock Split | 2025-09-18 | 3.78 (-1.05%) | ||
| Second quarter earnings results for 2025 | 2025-08-07 | 3.79 (-0.26%) | ||
| General meeting for 2025 | 2025-05-29 08:00 | 2.88 (-1.74%) |
Show
Entries
LeonaBio Inc Frequently Asked Questions
What is LeonaBio Inc(LONA)'s stock price today?
The current price of LONA is $8.70. The 52 week high of LONA is $14.21 and 52 week low is $2.95.
When is next earnings date of LeonaBio Inc(LONA)?
The next earnings date of LeonaBio Inc(LONA) is 2026-08-07 Est..
Does LeonaBio Inc(LONA) pay dividends? If so, how much?
LeonaBio Inc(LONA) does not pay dividend.
Guru Commentaries on NAS:LONA
No articles.
Press Release
Articles on LeonaBio Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers